April 2, 2020

Hear from public health experts on the situation in New York, an epicenter of the COVID-19 pandemic. Learn about the reality on the ground, what they need, what others can learn from their plight, what LMICs are facing, and what we must do now to bend the curve of the pandemic.


Cheryl G. Healton, DrPH
Dean, School of Global Public Health, New York University & Professor of Public Health Policy and Management
Dr. Cheryl Healton is responsible for building the School of Global Public Health’s academic, service, and research programs, which focus on domestic and international health with an emphasis on prevention, systems intervention, and innovation in public health practice. Previously, as the founding President and CEO of Legacy – a leading organization dedicated to tobacco control – Dr. Healton worked to further the foundation’s mission: to build a world where young people reject tobacco and anyone can quit. Prior to Legacy, Dr. Healton held numerous roles at Columbia University, worked to expand the scope of public health programs, and undertook innovative educational initiatives to advance public health practice.

Through her research, she has published over 100 peer-reviewed papers and special reports on public health related topics including HIV/AIDS, public health education, health policy, substance abuse, and tobacco. She was the founding chair of the Public Health Practice Council of the Association of Schools of Public Health and is an active member of the public health community, serving on the National Board of Public Health Examiners, the Betty Ford Institute, and Lung Cancer Alliance. She also serves on the Board of Directors at the Association of Schools and Programs of Public Health, and the Board of Directors at HealthRight International.

David R. Holtgrave, PhD
Dean, SUNY Empire Innovation & Professor, Distinguished Professor, School of Public Health
David Holtgrave, PhD, has served as the Dean of the School of Public Health, University at Albany, State University of New York since March 2018. He is also appointed as a SUNY Empire Innovation Professor and a SUNY Distinguished Professor. From August 2005 through February 2018, David served as Professor and Chair of the Department of Health, Behavior and Society at the Johns Hopkins Bloomberg School of Public Health. In July, 2017, he was appointed to hold the Inaugural Health, Behavior and Society Professorship (an endowed professorship). He also held joint appointments in the Johns Hopkins schools of medicine and nursing.

Dr. Holtgrave has worked extensively in the field of HIV prevention since 1991. His research has focused on the effectiveness and cost-effectiveness of HIV prevention interventions and the translation of those study findings to HIV prevention policy. Prior to his position at Johns Hopkins University, Dr. Holtgrave was a professor at the Rollins School of Public Health at Emory University. He also served as director of the Division of HIV/AIDS Prevention-Intervention Research and Support at the U.S. Centers for Disease Control and Prevention (CDC), as well as on the faculty at the Center for AIDS Intervention Research at the Medical College of Wisconsin. He has authored or co-authored over 300 professional publications.

Eli Rosenberg, PhD
Associate Professor, Epidemiology & Biostatistics, SUNY University at Albany
Dr. Rosenberg is an associate professor in the Department of Epidemiology and Biostatistics who is committed to infectious diseases epidemiological work to improve the health of persons in New York State and nationally. His research centers on applied and analytic epidemiologic studies that address current public health challenges in HIV, STI, viral hepatitis, and Zika surveillance, prevention, and social determinants. He has specifically focused on sexual and racial minorities, persons who inject drugs, and the infectious disease disparities they face, with considerable effort spent on cohort and modeling studies. Specific methodological interests include surveillance methods, statistical and network modeling, causal inference methods, and development of software to support research studies. This work has occurred across a diverse portfolio of projects supported by NIH, CDC, and NYS Department of Health.


Keith Martin, MD
Executive Director, CUGH
Dr. Martin is a physician who, since Sept. 2012, has served as the founding Executive Director of the Consortium of Universities for Global Health (CUGH). Between 1993-2011, Dr. Martin served as a Member of Parliament in Canada’s House of Commons. He held shadow ministerial portfolios in foreign affairs, international development, and health. He also served as Canada’s Parliamentary Secretary for Defense and was appointed to the Queen’s Privy Council for Canada. His main areas of focus are in global health, foreign policy, security, international development, conservation and the environment. Dr. Martin has served on numerous diplomatic missions to areas in crisis and served as a physician in South Africa on the Mozambique border during that country’s civil war. He has traveled widely in Africa, visiting the continent 28 times. He has had over 170 editorial articles published in major newspapers and has appeared frequently as a political and social commentator on television and radio.